Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
Juryńczyk
Maciej
M
Department of Neurology, Medical University of Lodz, Lodz, Poland.
Walczak
Agata
A
Jurewicz
Anna
A
Jesionek-Kupnicka
Dorota
D
Szczepanik
Marian
M
Selmaj
Krzysztof
K
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D015551:Autoimmunity / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D016207:Cytokines / Q000097:blood; D004338:Drug Combinations; D005260:Female; D006023:Glycoproteins / Q000008:administration & dosage; D006801:Humans; D008198:Lymph Nodes / Q000166:cytology; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology; D004676:Myelin Basic Protein / Q000008:administration & dosage; D009185:Myelin Proteins / Q000008:administration & dosage*; D018991:Myelin Proteolipid Protein / Q000008:administration & dosage; D063308:Myelin-Oligodendrocyte Glycoprotein; D010446:Peptide Fragments / Q000008:administration & dosage*; D012867:Skin / Q000276:immunology
D016207:Cytokines; D004338:Drug Combinations; D006023:Glycoproteins; D004676:Myelin Basic Protein; D009185:Myelin Proteins; D018991:Myelin Proteolipid Protein; D063308:Myelin-Oligodendrocyte Glycoprotein; D010446:Peptide Fragments; C107908:myelin basic protein 85-99; C445081:myelin oligodendrocyte glycoprotein (35-55); C435023:myelin proteolipid protein (139-151)